FDA approves Revolution Medicines pancreatic cancer drug Rasonque

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. AAPL
6. QCOM
7. IRT
8. ASO
9. LAES
10. PHVS

Go back to FDA approves Revolution Medicines pancreatic cancer drug Rasonque
(NASDAQ: RVMD) Delayed: 209.63 +2.31 (1.11%)
Previous Close $207.32    52 Week High $ 
Open $206.01    52 Week Low $ 
Day High $213.00    P/E N/A 
Day Low $204.46    EPS $ 
Volume 398,242